In addition, WHO has asked MOH to found a vaccine institute to deal with global epidemic threats. Given these factors, there is a need for private investment to establish an institute to manufacture essential vaccines, partnering a global manufacturer with a National Champion or experienced technical partners. The partnership will create an integrated mini cluster that comprises R&D, bulk production and formulation-and-fill-and-finish operations.

MOH will support this initiative by acquiring bacterial and viral seeds and cell lines to develop vaccine bulk.

  Time:

  Profile: Pre-fabricated element manufacturers demonstrating excellent quality and precision.

  Initial investment:

Market data

Jobs                              : 800

No of Projects                : 1

Market Size                   : TBD

To Be Determined

Source: Saudi Arabian General Investment Authority (SAGIA) www.sagia.gov.sa